PELP1 serves as a proto-oncogene in all hormone-responsive cancers, including breast, prostate cancers, ovarian, and other cancers (Dimple et al., 2008; Cortez et al., 2012; Yang et al., 2012; Daniel et al., 2015). Here, PELP1 is linked to prostate carcinoma.